Company overview
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing VANI with another company.
| Daily close (USD) | $1.23 |
| Market capitalization (USD) | $110,950,127.88 |
| Price / earnings (TTM) | Not reported |
| Price / book | 5.85 |
No matching rows. Clear the filter to see all records.
Read VANI's valuation metrics
Company size
Vivani Medical, Inc. Common Stock (DE)'s recorded market capitalization is $110,950,127.88. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
VANI's recorded price-to-book ratio is 5.85. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Vivani Medical, Inc. Common Stock (DE) with Aurora
Use the snapshot above to ask a specific question about VANI. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow VANI's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.